Form 8-K - Current report:
SEC Accession No. 0001193125-25-122468
Filing Date
2025-05-19
Accepted
2025-05-19 16:20:36
Documents
12
Period of Report
2025-05-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d105874d8k.htm   iXBRL 8-K 32367
  Complete submission text file 0001193125-25-122468.txt   146752

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA slrn-20250513.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE slrn-20250513_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slrn-20250513_pre.xml EX-101.PRE 11253
14 EXTRACTED XBRL INSTANCE DOCUMENT d105874d8k_htm.xml XML 3633
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-456-4393
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 25964228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)